Steve Yoelin

DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)

Vince Bertucci, Nowell Solish, Joely Kaufman‐Janette et al. · Journal of the American Academy of Dermatology · 2019 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study

Steve Yoelin, Sunil Dhawan, Domenico Vitarella et al. · Plastic & Reconstructive Surgery · 2018 · 53 citations

Medicine, Pharmacology, Biopharmaceutics +12

Safety, Effectiveness, and Subjective Experience with Topical Bimatoprost 0.03% for Eyelash Growth

Steve Yoelin, John G. Walt, Melissa Earl · Dermatologic Surgery · 2010 · 34 citations

Medicine, Dermatology, Ophthalmology +13

IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines

Martina Kerscher, Sabrina G. Fabi, Tanja Fischer et al. · Journal of Drugs in Dermatology · 2020 · 24 citations · Full text

Pharmacy, Pharmacology, Toxicology +6

A Prospective, Multicenter, Single-Blind, Randomized, Controlled Study of VYC-15L, a Hyaluronic Acid Filler, in Adults for Correction of Infraorbital Hollowing

Sabrina G. Fabi, Christopher I. Zoumalan, Steve Fagien et al. · Aesthetic Surgery Journal · 2021 · 16 citations · Full text

Medicine, Plastic Surgery, Surgery +14